We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Estimated Level of Plasma Micro RNA-210 in Beta Thalassemia Patients and Its Relation to Hemoglobin F Level and Disease Severity.
- Authors
Sharshera, Homam M.; El Maghraby, Shereen M.; Aglan, Shaimaa A.; Mikhael, Irene L.; Balbaa, Ola A.
- Abstract
BACKGROUND: Beta-thalassemia is an autosomal recessive hereditary blood disorder occurs due to absent or diminished ß-globin chains synthesis. The transformation from fetal to adult in globin synthesis is controlled by different mechanisms; one of those is BCL11A which is downregulated by microRNA-210 (miRNA-210). Therefore, this would lead to reactivation of fetal hemoglobin (HbF) production that improves anemia and reduces the needs for transfusion. OBJECTIVE: To study miRNA-210 in the plasma of beta thalassemia patients and its relation to HbF level and disease severity. SUBJECTS AND METHODS: The study was carried out on 50 individuals divided into three groups. Group A included 30 thalassemia major patients, Group B included 10 thalassemia intermedia patients, and Group C is 10 healthy volunteers as control. All individuals underwent to history taking, physical examination, and laboratory investigations, complete blood count, serum ferritin, hemoglobin electrophoresis, and measurement of miRNA-210 expression levels in plasma of peripheral blood samples by quantitative real-time polymerase chain reaction. RESULTS: Examination of miRNA-210 plasma level among different groups revealed no statistically significant association between control and thalassemia group or its subgroups (Major and intermedia) (P = 0.224, P = 0.116, and P = 0.734, respectively). Moreover, miRNA-210 was slightly higher in responders than nonresponders to hydroxyurea but did not reach significant level. CONCLUSION: miRNA-210 levels were not associated with increase in HbF levels in thalassemia patients.
- Subjects
EGYPT; BIOMARKERS; PHYSICAL diagnosis; REVERSE transcriptase polymerase chain reaction; KRUSKAL-Wallis Test; STATISTICS; RETICULOCYTES; HEMATOCRIT; HYDROXYUREA; FERRITIN; SERUM; BLOOD plasma; ELECTROPHORESIS; MICRORNA; CASE-control method; BLOOD collection; MANN Whitney U Test; TREATMENT effectiveness; COMPARATIVE studies; GENE expression; MEDICAL history taking; DESCRIPTIVE statistics; CHI-squared test; BLOOD cell count; DATA analysis software; DATA analysis; ERYTHROCYTES; FETAL hemoglobin; BETA-Thalassemia; BLOOD
- Publication
Journal of Applied Hematology, 2023, Vol 14, Issue 3, p208
- ISSN
1658-5127
- Publication type
Article
- DOI
10.4103/joah.joah_42_23